1 March 2023 v2024.58.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsetruexbrli:purexbrli:sharesiso4217:GBP089024542023-03-012024-02-29089024542024-02-29089024542023-02-2808902454core:WithinOneYear2024-02-2908902454core:WithinOneYear2023-02-2808902454core:ShareCapital2024-02-2908902454core:ShareCapital2023-02-2808902454core:RetainedEarningsAccumulatedLosses2024-02-2908902454bus:Director12023-03-012024-02-2908902454bus:Director22023-03-012024-02-2908902454core:OfficeEquipment2023-03-012024-02-29089024542022-03-012023-02-2808902454core:PlantMachinery2023-03-0108902454core:PlantMachinery2023-03-012024-02-2908902454core:PlantMachinery2024-02-2908902454core:PlantMachinery2023-02-280890245412023-03-012024-02-2908902454countries:EnglandWales2023-03-012024-02-2908902454bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2908902454bus:PrivateLimitedCompanyLtd2023-03-012024-02-2908902454bus:SmallEntities2023-03-012024-02-2908902454bus:FullAccounts2023-03-012024-02-29
Company registration number:
08902454
Coalescence Ltd
Unaudited Filleted Financial Statements for the year ended
29 February 2024
Coalescence Ltd
Statement of Financial Position
29 February 2024
20242023
Note££
Fixed assets    
Tangible assets 5
3,811
 
1,022
 
Current assets    
Debtors 6
9,999
  -  
Cash at bank and in hand
11,843
 
20,422
 
21,842
 
20,422
 
Creditors: amounts falling due within one year 7
(16,399
)
(21,344
)
Net current assets/(liabilities)
5,443
 
(922
)
Total assets less current liabilities 9,254   100  
Capital and reserves    
Called up share capital
100
 
100
 
Profit and loss account
9,154
  -  
Shareholders funds
9,254
 
100
 
For the year ending
29 February 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
18 November 2024
, and are signed on behalf of the board by:
Mr. D Watts
Mrs. L Watts
DirectorDirector
Company registration number:
08902454
Coalescence Ltd
Notes to the Financial Statements
Year ended
29 February 2024

1 General information

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Office equipment
33% straight line

4 Average number of employees

The average number of persons employed by the company during the year was
2
(2023:
2.00
).

5 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 March 2023
7,381
 
Additions
3,765
 
At
29 February 2024
11,146
 
Depreciation  
At
1 March 2023
6,359
 
Charge
976
 
At
29 February 2024
7,335
 
Carrying amount  
At
29 February 2024
3,811
 
At 28 February 2023
1,022
 

6 Debtors

20242023
££
Other debtors
9,999
  -  

7 Creditors: amounts falling due within one year

20242023
££
Taxation and social security
16,399
 
19,266
 
Other creditors -  
2,078
 
16,399
 
21,344
 

8 Directors' advances, credit and guarantees

During the year Coalescence Ltd made an unsecured interest free loan to Mr. David Watts. The balance of the loan £10,000 is repayable on demand and in full. The balance at the year end was £10,000.